-
-
Call more information
660-596-2224 -
Author: Paige Haeffele Becker’s ASC Review In wake of CMS’ finalized physician fee schedule, which cut physician pay by 3.4% compared to last year despite rising inflation and practice costs, some practices and physicians made the decision to drop Medicare patients. When adjusting for inflation, Medicare already pays around 26% less than it did in 2001 to […]
Read MoreAuthors: Mathias Maagaard, M.D. et al Anesthesiology June 2023, Vol. 138, 625–633. Background The authors hypothesized that both perineural and systemic dexamethasone as adjuncts to bupivacaine increase the duration of an ulnar nerve block compared with bupivacaine alone, and that systemic dexamethasone is noninferior to perineural dexamethasone. Methods The authors performed bilateral ulnar nerve blocks with […]
Read MoreAuthor: Rebecca Pifer Healthcare Dive Payers have new deadlines to issue prior authorization decisions — 72 hours for urgent requests and seven days for non-urgent ones. Dive Brief: Federally regulated health insurers — including Medicare Advantage plans — will have to turn around prior authorization decisions much more quickly under a rule finalized by the CMS […]
Read MoreAUTHORS: Engoren, Milo MD; Heung, Michael MD Anesthesia & Analgesia February 12, 2024. BACKGROUND: Sugammadex is associated with fewer postoperative pulmonary complications than is neostigmine reversal of neuromuscular blockade. However, the Food and Drug Administration-approved package insert states that its use is “not recommended” in severe renal impairment, separately defined as creatinine clearance <30 mL/min. […]
Read MoreAUTHORS: Yeh, Chou-Ming MD, PhD et al Anesthesia & Analgesia June 30, 2023. BACKGROUND: Paclitaxel (PTX), which is a first-line chemotherapy drug used to treat various types of cancers, exhibits peripheral neuropathy as a common side effect that is difficult to treat. Protein arginine methyltransferase 5 (PRMT 5) is a key regulator of the chemotherapy […]
Read More